O
Ondine Biomedical Inc
LSE:OBI
Ondine Biomedical Inc
LSE:OBI
Price:
11.25
GBX
2.27%
Market Closed
Market Cap:
£58.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
CA |
|
L
|
Liberty Global PLC
LSE:0XHS
|
UK |
|
D
|
DTC Industries PCL
SET:DTCI
|
TH |
|
Athersys Inc
OTC:ATHXQ
|
US |
|
Marijuana Company Of America Inc
OTC:MCOA
|
US |
|
B
|
Becton Dickinson and Co
DUS:BOX
|
US |
|
S
|
System1 Group PLC
F:BBA
|
UK |
|
Dyo Boya Fabrikalari Sanayi Ve Ticaret AS
IST:DYOBY.E
|
TR |
|
P
|
Planet Fitness Inc
F:3PL
|
US |
|
A
|
Alpha Star Acquisition Corp
NASDAQ:ALSA
|
US |
|
P
|
Prima Marine PCL
SET:PRM
|
TH |
|
CubicFarm Systems Corp
XTSX:CUB
|
CA |
|
Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk PT
IDX:JMAS
|
ID |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is OBI's stock price target?
Not Available
OBI does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Ondine Biomedical Inc?
Projected CAGR
270%
270%
Over the last 4 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 2 years is 270%.
What is the Gross Profit forecast for Ondine Biomedical Inc?
Projected CAGR
15%
15%
Over the last 4 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 1 year is 15%.
